Cardiovascular Drug Reviews

12.0k citations
469 papers · · active since 1950

Impact in

Papers in

Cardiovascular Drug Reviews

452 papers receiving 11.4k citations

Peers

Cardiovascular Drug Reviews
Comparison fields: 5 of 156
  • Cardiology and Cardiovascular Medicine 3.3k
  • Internal Medicine 394
  • Geriatrics and Gerontology 302
  • Endocrinology, Diabetes and Metabolism 1.1k
  • Pharmacology 1.1k
Replace Critical Reviews in Clinical Laboratory Sciences with:
Critical Reviews in Clinical Laboratory Sciences United States
Advances in clinical chemistry United States
JACC Basic to Translational Science United States
Archivum Immunologiae et Therapiae Experimentalis Poland
Circulation Cardiovascular Genetics United States
Cardiovascular & Hematological Agents in Medicinal Chemistry United States
Annual Review of Pathology Mechanisms of Disease United States
Therapeutic Advances in Cardiovascular Disease United States
Critical Reviews in Biochemistry and Molecular Biology United States
Journal of Pharmacology and Pharmacotherapeutics India
Cardiovascular Drug Reviews relative to Critical Reviews in Clinical Laboratory Sciences United States Critical Reviews in Clinical Laboratory Sciences's profile →
Citations per field
00.5×1.5×2.0×
Critical Reviews in Clinical Laboratory Sciences · 1×
Citations per year

Countries where authors publish in Cardiovascular Drug Reviews

Since Specialization
Citations

This map shows the geographic impact of research published in Cardiovascular Drug Reviews. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers published in Cardiovascular Drug Reviews with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cardiovascular Drug Reviews more than expected).

Fields of papers published in Cardiovascular Drug Reviews

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers published in Cardiovascular Drug Reviews. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers published in Cardiovascular Drug Reviews.

About Cardiovascular Drug Reviews

The 469 papers published in Cardiovascular Drug Reviews in the last decades have received a total of 12.0k indexed citations . Papers published in Cardiovascular Drug Reviews usually cover Cardiology and Cardiovascular Medicine (243 papers), Analytical Chemistry (42 papers), Internal Medicine (13 papers), Pharmacology (58 papers) and Endocrinology, Diabetes and Metabolism (53 papers) specifically the topics of Cardiac electrophysiology and arrhythmias (115 papers), Receptor Mechanisms and Signaling (69 papers), Ion channel regulation and function (59 papers), Nitric Oxide and Endothelin Effects (42 papers), Analytical Methods in Pharmaceuticals (41 papers), Antiplatelet Therapy and Cardiovascular Diseases (38 papers), Heart Failure Treatment and Management (36 papers) and Cardiac Ischemia and Reperfusion (35 papers). The most active scholars publishing in Cardiovascular Drug Reviews are Kailash Prasad, Alessandro Villa, Silvia Bradamante, Livia Barenghi, Ruitang Deng, Johan A. Moolman, Amanda Lochner, Pál Pacher, Csaba Szabó and David S. Goldstein.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore journals with similar magnitude of impact